Allergan, Soccer, Golf, Kennedy: Intellectual Property

June 11 (Bloomberg) -- Allergan Inc., maker of the Botox wrinkle treatment, lost an appeals court ruling that will let generic versions of its Latisse eyelash drug enter the market.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.